The 11 best electric toothbrushes for 2025, tested and reviewed
The best electric toothbrushes for 2025
Other top electric toothbrushes we recommend for 2025
Factors to consider when choosing an electric toothbrush
Other electric toothbrushes we've tested
Electric toothbrush FAQs
Meet our experts
Updated July 7, 2025: We updated prices and checked stock for all products. Our best overall pick is more than 20 percent off for Amazon Prime Day right now.
(back to top)
(back to top)
Electric toothbrushes tend to vary based on their brush head size and bristle type. Many have additional key features that can help to improve oral health and your overall brushing experience.
Brush head size: Bigger isn't always better when it comes to toothbrush heads. Sheila Samaddar, DDS, a dentist practicing in Washington, D.C. says that smaller brush heads are often more effective, especially for reaching difficult areas. A compact brush head can maneuver around tight spaces in your mouth with greater precision, ensuring a thorough clean. Look for one that puts maneuverability over size.
Bristle type: The type of bristles on your electric toothbrush aren't simply a matter of preference. And while you might think that firmer bristles provide a deeper clean, Joseph Goodman a cosmetic dentist based in Beverly Hills, Calif., recommends opting for soft bristles endorsed by the American Dental Association (ADA). Hard bristles can potentially harm enamel and root surfaces, leading to long-term damage. Soft bristles offer gentle yet effective cleaning without causing undue harm to your teeth and gums.
Key features: If you struggle with brushing long enough, you can look for a toothbrush with built-in timers or reminders. These features can alert you every 30 seconds, prompting you to switch to a different quadrant of your mouth for a comprehensive clean. Additionally, if you share your toothbrush base with family members, consider a model that allows for easy head swapping. Ergonomic design and multiple setting options are also crucial factors to consider. A toothbrush with an easy-to-grip handle and adjustable settings is ideal. Cu recommends starting with a "sensitive" setting.
(back to top)
We've actually put hundreds of oral healthcare products to the test, including a range of manual and electric toothbrushes, water flossers, whitening toothpastes and dental hygiene tools like floss and tongue scrapers. In addition to the products listed above, we've also tried (and liked) the following:
Burst Curve Sonic Toothbrush: Our tester really liked the convenience of the subscription and how pretty the toothbrush looked in her bathroom, but she felt it didn't clean her teeth as well as she had hoped, so she wouldn't plan on giving it another go unless the brush was redesigned and optimized for a deeper clean.
Aquasonic Vibe Series Ultra-Whitening Toothbrush: This is very similar to our top overall pick — the AquaSonic Black Series — and has the same four cleaning modes, as well as the 40,000-vibrations-per-minute technology. It also comes with eight brush heads and a travel case. This one easily could have taken the top spot, but our tester (who also tested the Black Series) noted that the Black Series looks a little bit sleeker, which upped its rating. That said, this one ranked highest in our testing of 20 manual and electric toothbrushes, so it's clearly a solid all-around choice.
Oral-B Genius 8000 Electric Toothbrush: Our tester was initially drawn to this toothbrush for its app-connected tracking capabilities. While she enjoyed that it showed her 'how well I brushed and where I needed to brush more as well as the pressure with which I brushed,' she added that sometimes 'you just want to brush your teeth without bringing your phone into the bathroom and risking it falling into the sink or ... toilet!' Maybe there was something to her concerns because this toothbrush is no longer available at major retailers or on the Oral-B website.
Philips Sonicare 9900 Prestige Electric Power Toothbrush: In testing 20 different manual and electric brushes, this model from Philips actually came out on top. However, it's an expensive option at $329.
SpinBrush Pro+: If you're looking for a budget pick that does the trick, this low-cost SpinBrush+ comes in handy. It's battery-powered, so there are no charging ports or wires to contend with. It makes a great pick if you're a frequent traveler — just toss it in your Dopp kit to have ready wherever you go.
Suri Electric Toothbrush: This toothbrush may be a good pick if you're conscientious about the environment as it's made from plant-based materials. The company also offers a mail-in recylcing program for your used brush heads. That said, it didn't leave our tester with quite the teeth cleaning she was hoping for, although she did like the brush's "polishing" mode.
Willo AutoFlo+: Granted, this kids' toothbrush is spendy, but in terms of automating the teeth-brushing experience for kids 8-11, our tester loved this pick. She says her son was a fan and she was confident he was getting an especially clean mouth with each brush. Unfortunately, it's not yet ADA approved, so it loses points on that front.
Ordo Sonic+ Toothbrush: While this is a no-fuss, reasonably priced electric toothbrush, we found that it was prone to shedding bristles during our testing period.
Quip Ultra Next Generation Smart Sonic Toothbrush: While we found this to be a quality electric toothbrush, and our tester liked the pressure sensor and the ability to customize the brush intensity, she didn't like it as much as other electric brushes she tested. And, she noted that it's more affordable than many similar brushes.
Supermouth Ultim8 Smart-Brush System: Our tester noted that after trying many electric toothbrushes, this one deserves an honorable mention. The full system costs about $200, but she noted that it left her mouth feeling "ultra clean." She also liked that this is a waterproof toothbrush which makes it a good option for anyone who likes to brush their teeth in the shower.
(back to top)
According to cosmetic and reconstructive dentist Lior Tamir, 'The purpose of a toothbrush is to physically remove plaque from the teeth. Plaque is the decomposed food and bacteria that cause cavities. Electric toothbrushes have been clinically shown to be significantly more effective at removing plaque from the teeth.'
Besides giving you that fresh-from-the-dentist feeling, using an electric toothbrush can also help improve your brushing habits. Cu tells Yahoo Life, 'One of the biggest benefits to using an electric toothbrush is consistency — we have our great days and our lazy ones, but our electric toothbrush will brush our teeth the same way every time.' Hence, that's the reason why most options feature a two-minute timer that lets you know exactly when you've hit your goal.
While sonic toothbrushes are in the electric toothbrush family, there are a few differences. 'Regular electric toothbrushes have rotating heads that can spin several thousand times per minute, but sonic toothbrushes spin tens of thousands of times per minute, which can give you a cleaner smile in a shorter period of time,' says Goodman.
The short answer is yes. While it's still recommended to brush for two minutes whether you use electric or manual, electric toothbrushes make it so you do less of the work. According to Dr. Jeffrey Rappaport chief dental adviser at Quip, an oral care company, 'For a sonic/electric brush, the vibrations and/or brush movements do a lot of the brushing work for you; therefore, you should be gentler when maneuvering the brush around your mouth. Be sure to move the brush slowly around each tooth to ensure the vibrations and/or brush movements have enough time to clean effectively.'
No matter what you're using, Rappaport said, 'Remember to be gentle with your teeth and gums, as brushing too hard can hurt your teeth and gums and cause them to recede.'
Think you might be ready to take the plunge and go electric? Good, because we've tested out nearly 20 options to see which worked the best. Keep reading to see all 11 of the best electric toothbrushes.
(back to top)
Dr. Joseph Goodman, cosmetic dentist in Beverly Hills, Calif.
Dr. Jeffrey Rappaport, chief dental adviser at Quip in N.Y.
Dr. Chrystle Cu, DDS and cofounder of Cocofloss in San Mateo, Calif.
Dr. Lior Tamir, cosmetic and reconstructive dentist in San Mateo, Calif.
Dr. Sheila Samaddar, dentist practicing in Washington, D.C.
(back to top)
Our health content is for informational purposes only and is not intended as professional medical advice. Consult a medical professional on questions about your health.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Magazine
9 hours ago
- Time Magazine
Trump's Medicaid Cuts Put People with Disabilities at Risk
Today marks the 35th anniversary of the Americans with Disabilities Act (ADA). This landmark legislation, which enshrined in federal statute civil rights for people living with disabilities, has transformed countless lives. It opened the world up to an entire population who, until that point, were more often than not excluded and isolated from society. It codified a legal pathway for equality and inclusion by dismantling longstanding barriers that prevented people with disabilities from having the opportunity to pursue employment, live independently, access transportation and public spaces, and so much more. The ADA affirmed the fundamental right of every American to participate fully in society, and is foundational to ensuring that those with intellectual and developmental disabilities (I/DD) have equal opportunities to thrive and live with autonomy. Yet, as we celebrate the ADA's enduring legacy this year, the future for people with disabilities looks less certain. The ADA's vision is not self-sustaining. Its promise is fulfilled through an ecosystem of vital support services, many of which rely on Medicaid funding. For millions of Americans living with disabilities, Medicaid is a lifeline that provides access to essential home- and community-based services (HCBS). These services include the most basic activities of daily living like bathing, dressing, eating, and more, as well as the residential programs, employment supports, and assistive technologies that allow people with I/DD to live with dignity in their own homes and communities. These services are at the heart of the ADA and crucial to making inclusion a reality. Following the passage of President Donald Trump's tax bill, which will cut aproximately $1 trillion from Medicaid over the next several years, these support systems are in jeopardy. This attack on Medicaid threatens to unravel decades of progress toward equal opportunity for individuals with disabilities, as access to these services will undoubtedly become more limited. Read More: The Big Budget Bill Could Make Your ER a Mess Cuts to Medicaid could mean fewer available care services, longer waiting lists for critical support, and potentially the loss of the very assistance that allows those with I/DD to live independent and fulfilling lives. Imagine losing the career coach who helps you get ready for work and makes it possible to maintain steady employment, or the direct support professional (DSP) who helps you bathe and brush your teeth, or the transportation service that connects you to your community. These cuts translate into a forced retreat from independence, pushing individuals back into isolation and dependency, often in hospitals or costly, state-run institutions, directly contradicting the ADA's core tenets. The ripple effect extends to the dedicated community providers who are the backbone of the HCBS ecosystem. These organizations operate on thin margins, relying heavily, or solely, on Medicaid to fund their services. Cuts of this size may fall heavily on providers, who are already in crisis because of long-term underinvestment in community-based services, leaving them struggling to offer their DSPs competitive wages and benefits due to stagnant and insufficient reimbursement rates. Ultimately, these cuts could lead to reduced capacity, staff layoffs, and even the closure of programs. The national shortage of DSPs is also expected to worsen. To pay wages, providers rely on Medicaid reimbursements from their states; if states are rendered unable to increase reimbursement rates, providers will lose the DSPs they employ to better-paying opportunities in other hourly wage industries such as fast food and retail. This monumental blow to Medicaid funding will make it even harder to find and retain the individuals who provide day-to-day care. Troublingly, these DSPs, whose work is both physically and emotionally demanding, often rely on Medicaid themselves due to insufficient wages. When providers are forced to scale back programs or shutter entirely, the entire HCBS infrastructure weakens, leaving countless individuals without the support they need. The strain is then placed on the families of people with I/DD, potentially forcing some to leave their own jobs to provide care for their loved ones. For the many individuals with I/DD who don't have family or existing networks of support, access to care may be lost completely. Read More: The GOP Budget Takes From the Poor and Gives to the Rich The true scale of the impact remains to be seen, but there is no doubt that it will be nothing short of devastating. A nearly $1 trillion cut to Medicaid is not just a budgetary change. It will harm people with disabilities and the progress we have made since the passage of the ADA. Decades of advocacy, innovation, and hard-won victories for equality and inclusion are at risk of being rolled back. As we honor the ADA this year, we must recommit to its vision by unequivocally protecting the very funding that makes true community living and inclusion a reality for all. We cannot allow the fundamental rights and opportunities of people with disabilities to be undermined. Solutions must be found, advocates must fight back, and state leaders need to find ways to preserve funding for these vital services. Access to care is not a luxury, it is a necessity that is integral to upholding the rights of those with disabilities.
Yahoo
a day ago
- Yahoo
Endocrinologists Are Begging People With High A1C Levels To Stop Doing This One Thing ASAP
Endocrinologists Are Begging People With High A1C Levels To Stop Doing This One Thing ASAP originally appeared on Parade. More than than one in 10 American adults has some form of diabetes and, of those, up to 95% have type 2 diabetes. Having this condition means needing to be on top of your glucose levels, including your A1C levels, an average measure of your blood sugar over two to three months. High A1C levels usually mean you have diabetes, but it can also be a marker of prediabetes, a condition in which your blood sugar is elevated but not quite high enough for a type 2 diabetes diagnosis, according to the American Diabetes Association (ADA).Why does this matter? Having high A1C indicates that your body isn't using blood sugar properly. 'The goal function of the body is to place sugar from the food into cells to nourish,' explains , endocrinologist and assistant professor of medicine at GW Medical Faculty Associates. 'Failure of this process is when sugar from food is absorbed into the blood, but cannot move into cells either due to insulin resistance or deficiency.' When that consistently happens, you could be at risk of developing organ damage to your kidneys, eyes, heart and nerves, Dr. Baldwin says. If you have elevated A1C levels or have already been diagnosed with type 2 diabetes, it's best to aim for an A1C that's less than 7%, per the ADA. (If your A1C level lands between 5.7% and 6.5%, you're considered to have prediabetes.)Related: 'Maintaining a healthy A1C indicates that your blood sugar is not high and that greatly reduces the risk of long-term complications,' says , chief of the division of endocrinology at Rutgers Robert Wood Johnson Medical 2 diabetes is a complicated condition, and it's hard to say that doing any one thing will help your A1C levels come back down. But endocrinologists stress that certain lifestyle factors are crucial with blood sugar control, even if you're on medication. While endocrinologists say it's important to tackle blood sugar control from a variety of angles, there's one habit they repeatedly encourage their patients with high A1C to break.🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 The No. 1 Habit Endocrinologists Want People With High A1C To Break ASAP Endocrinologists recommend that people with high A1C rethink how much fast food they eat. 'Fast food typically contains ultra-processed foods that can be toxic to beta cells—cells in the pancreas that produce insulin,' Dr. Baldwin says. (In case you're not familiar with it, insulin is a hormone that helps sugar enter cells, where it's used for energy.)While there is a range with fast food, she points out that foods in this category tend to be high in simple carbohydrates. These carbs 'can be rapidly metabolized into sugar, compounding the problem.' When you eat a lot of simple carbs, it can cause your blood sugar to spike and then crash, making symptoms of type 2 diabetes—and your A1C levels—worse, Dr. Buettner says. Related: Fast foods also tend to be high in saturated fat, which can worsen your body's ability to use insulin properly, according to Dr. Buettner. It's also often low in fiber (a nutrient that lowers blood sugar), and high in calories, raising the odds of weight gain and worsening blood glucose control, he explains, adding, 'These factors make it harder to manage blood sugar and maintain or lower your A1C."Things that tend to go along with fast food can also be problematic for blood sugar management, points out , endocrinologist and obesity medicine specialist at NYU Langone Health. 'Fast food is frequently consumed alongside sugar-sweetened beverages like soda, compounding the glycemic impact,' she says. Even if fast food isn't a consistent thing for you, Dr. Baldwin suggests being mindful of ultra-processed foods. These are foods that are altered from their usual state and have added ingredients like artificial colors and flavors, along with preservatives for shelf stability and ingredients to preserve texture. (Ultra-processed foods usually come in a package.)Related:Cardiologists Are Begging People With High Cholesterol to Stop Doing This One Thing ASAP Foods To Focus on Instead There's no one diet that's going to be "perfect" for every single person with Type 2 diabetes. But the ADA has certain guidelines to help you make choices to support better blood sugar management in the future. 1. Opt for non-starchy vegetables This should be the foundation of your plate. These vegetables, which include broccoli, cauliflower and spinach, are a good choice because they help fill you up without delivering as many calories and carbs as starchier foods. 2. Eat plenty of protein Protein is a macronutrient that can help fill you up and support muscle growth. The recommended daily allowance (RDA) of protein is 0.8 grams per kilogram per day for people aged 18 and up, which translates to about 30 to 35 grams of protein per meal for most people. If you eat a plant-based diet, the ADA recommends focusing on beans, hummus, and lentils. Just be aware that these foods have carbs, which may impact your blood 3. Try to limit carbs when you can Dr. Buettner suggests being mindful of how many carbs you're eating. 'Do not eat a lot of carbs as they get broken down to glucose in your body and raise blood sugar,' he says. 4. Enjoy fruit too Fruits count as carbohydrates, but they're different from, say, having white bread thanks to their vitamin, minerals and fiber content. 5. Mix in healthy fats Healthy fats, which include monounsaturated and polyunsaturated fats, can help regulate blood sugar and protect your heart. The ADA suggests focusing on olive oil, nuts, avocados and certain types of fish. 6. Load up on nutrient-dense food Foods with high nutritional value support good blood sugar management while giving you the vitamins and minerals you need for good health. The ADA suggests looking for foods that have a good mix of protein, healthy fats, vitamins, minerals and fiber. 7. Hydrate responsibly Water and zero-calorie drinks are a better choice for blood sugar management than options that contain added sugar, per the the ADA recommends using the "diabetes plate" strategy. This is designed to be a jumping-off point for creating healthy meals. With this strategy, take a nine-inch plate and fill half of it with non-starchy vegetables (think: broccoli, spinach, asparagus). From there, have lean proteins fill one-quarter of your plate. The other one-quarter should focus on quality carbs like starchy vegetables, fruits, low-fat dairy products or whole grains.'Portion control and consistent meal timing help reduce glucose variability throughout the day,' says Dr. Jaisinghani. Focusing on good hydration, quality sleep and doing what you can to manage stress levels is also important, she adds. Of course, if you know you have high A1C levels and you've done all of this, it's important to talk to your healthcare provider. They should be able to look at your current management strategy and provide personalized advice from there. Up Next:Sources: Type 2 Diabetes. Centers for Disease Control and Prevention What Is the A1C Test? American Diabetes Association Dr. Chelsey Baldwin, MD, endocrinologist and assistant professor of medicine at GW Medical Faculty Associates Dr. Christoph Buettner, MD, Ph.D., chief of the division of endocrinology at Rutgers Robert Wood Johnson Medical School Dr. Priya Jaisinghani, MD, endocrinologist and obesity medicine specialist at NYU Langone Health Petrus, R.; Sobral, P.; et al. The NOVA classification system: A critical perspective in food science, Trends in Food Science & Technology, 2021. Tips for Eating Well. American Diabetes Association Endocrinologists Are Begging People With High A1C Levels To Stop Doing This One Thing ASAP first appeared on Parade on Jul 24, 2025 This story was originally reported by Parade on Jul 24, 2025, where it first appeared. Solve the daily Crossword
Medscape
a day ago
- Medscape
ADA 2025: Clinical Trial Data on Incretin Therapies
This transcript has been edited for clarity. At the ADA meetings this year, incretin therapies were a big topic. There were many, many different studies presented on all sorts of new drugs and older drugs, and a large amount of interest in this. What I'm going to try to do is make it simple, and you're going to have to forgive me because many of these drugs have names that are almost impossible to pronounce. As far as I can tell, there were three main areas that involved incretins. One was newer agents that were different combinations of different kinds of drugs. I'm going to touch on those main areas where there were differences. The second is in terms of the forms for delivery, specifically a new oral form of incretin therapy that might be easier for patients to take. Third, longer duration of activity of these agents that might make it even easier for our patients to adhere to. First, I'm going to go to different combinations. The first is CagriSema, which is semaglutide plus cagrilintide, which is a long-acting human amylin analog. We all were familiar with amylin from a long while ago, as we had pramlintide. This takes that amylin analog and mixes it with a dose of 2.4 mg of semaglutide. The studies that they did are called REDEFINE, and they presented the full results of the phase 3 REDEFINE trials. In most of the studies on these newer agents, they basically study them in people who are overweight or obese without type 2 diabetes, as well as in people who are overweight or obese with type 2 diabetes. REDEFINE 1 looked at 3417 people who were overweight or obese and who didn't have type 2 diabetes. They saw 20% weight loss with this new agent compared to 15% with semaglutide 2.4 mg, or 12% weight loss with cagrilintide alone. In REDEFINE 2, there were 1206 people with obesity and type 2 diabetes compared to placebo. CagriSema conferred a 13.7% weight loss vs 3.4% with placebo. That's fairly standard for many of these drugs. You get weight loss and A1c reduction, and it's always a bit more in people without diabetes than those who have diabetes. Moving on to the next combination. There was the DREAMS-1 trial, looking at a once-weekly GLP-1 receptor agonist combined with a glucagon receptor agonist, which is called mazdutide. It was studied in people in China with type 2 diabetes. This showed a nice A1c reduction and significant weight loss at 24 weeks. This was a study in 319 individuals who were living in China. They had a number of different arms to this study, so they had a 4-mg dose, a 6-mg dose, and placebo. The study lasted for 24 weeks, and they saw A1c reductions of 1.4%-2%. There was weight loss that varied depending on the dose, at 5.6% or 7.8% in the two different arms. There were similar side effects. I think one of the truths of all of these trials is that the GI side effects occur with nearly all of these agents, some to a greater degree than others, but those were the major side effects in terms of this agent. They're now studying it in other individuals with type 2 diabetes. They compared it to dulaglutide and found a greater A1c reduction than with dulaglutide in one trial. They're also looking at it for weight loss in people without diabetes. There are a number of trials that are ongoing that will give us more data in terms of what this combination does in people with obesity and type 2 diabetes. The next trial is one that I find oddly fascinating, which is called the BELIEVE trial. Believe it or not, this is a trial in which they took semaglutide and mixed it with a monoclonal antibody that blocks activin type II receptors, with the hopes that that will improve muscle mass, maintain lean body mass, and decrease fat mass as people lose weight with this combination. They studied it in people who were living with obesity or overweight without type 2 diabetes, and they basically had a number of different comparisons. The monoclonal antibody is called bimagrumab. It's something that I'm not familiar with, but it was really interesting in terms of its effect. They had a number of different groups: a placebo group, a low-dose bimagrumab group, a high-dose bimagrumab group, a low-dose semaglutide group, and a high-dose semaglutide group, and then they had four different combination groups with low-dose or high-dose bimagrumab. They looked at all of these different permutations in a study sample size that was 507 individuals. They were hoping to see less loss of lean body mass, and they basically showed this. There was a 7.9% reduction in lean body mass with semaglutide alone, but if you gave them the monoclonal antibody, there was a 2.3% gain in lean body mass. When you combined the monoclonal antibody with semaglutide, you got a lesser reduction in lean body mass, a 2.6% reduction, which was compared to the 7.9% reduction with semaglutide alone. This is hopeful in the sense that this specific combination helps people lose less lean body mass. There were a whole bunch of other analyses they did to see about people being stronger and feeling better. It really does matter to not lose so much lean body mass. I'm still old fashioned and I really want to encourage people to exercise and eat well in order to help preserve lean body mass. We'll see what happens with this. I think it's a fascinating concept, but I also don't want to forget about lifestyle. The next trial was called ACHIEVE-1, and this was looking at an oral form of a GLP-1 receptor agonist known as orforglipron. They studied this in people with type 2 diabetes. What's different about this is that this is a small molecule. It's not a peptide GLP-1, so it's really easy to give. It's like any old pill that people take, so it doesn't have restrictions around how much water and when it's taken, etc. They did see benefit in terms of A1c reduction, some weight loss, about 8%, and it seemed like it worked, but it did have GI side effects and it didn't cause the same sort of A1c reduction or weight loss we see with some of the other injectable compounds. Still, it might be an interesting first step for people as they get used to GLP-1 receptor agonist therapy, and it may be easier for patients to take. The final compound I'm going to discuss is MariTide. This is a compound that is a GLP-1 receptor agonist and a GIP antagonist. This is a once-a-month agent. This was a 52-week trial in individuals who were obese or overweight without type 2 diabetes. They basically had three different doses they were studying and they did a bunch of different dosing frequencies. It seemed to me to be effective in terms of weight loss, as most of these drugs are, but it did have an incredibly high rate of GI side effects. When you look at that study in individuals without type 2 diabetes, the rates of nausea and vomiting were really high. At baseline, 25% of placebo patients reported nausea. In the treatment group, nausea was reported in 77%-87% of participants and vomiting was reported in 68%-92%. It usually occurred after the very first dose of the drug, with an incidence decreasing over time. I've never used a drug that had such a high rate of vomiting — nausea, potentially, but not vomiting. GI side effects were the main reason for people stopping it, and 14%-29% of individuals discontinued the drug due to adverse events. They also did a study in people with type 2 diabetes. It's interesting because they used a different survey to assess GI side effects, but they still had a very high rate of GI side effects, at 94% in the MariTide group vs 81% in the placebo group. Again, the most common GI side effects were nausea, vomiting, constipation, and diarrhea. Nausea rates ranged from 41% to 59% of people taking the MariTide, with vomiting in 45%-75% of participants. These GI side effects are really clear here, and I don't know that this is going to be something people are going to want to take. Once a month is nice, but it's not fun to vomit. I think it depends on how quickly people habituate to this and how one goes up on the dose. These GI side effects are an issue for all of us and our patients as we prescribe these drugs. I tend to start as low as I possibly can. I'm a fan of microdosing as much as possible to get people to tolerate these drugs because I think that the incretin class of drugs is so beneficial, not only in terms of glucose and weight loss, but also in its nonglycemic effects. I also don't want people to lose weight too fast because I think that it isn't healthy. I know that there are studies that are coming out that show that there are people who respond by very rapid weight loss, more commonly in women than in men. I think we need to be mindful of how we use these drugs, how quickly people lose weight, and how we encourage people in terms of leading a healthier lifestyle to avoid some of the side effects that can be associated with that sort of rapid weight loss. This has been Dr Anne Peters for Medscape.
